TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/10/2023
Voltar para busca
Dado oficial do USPTO
GAMIFANT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
29/10/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
29/12/2016
Data de registro
03/07/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/07/2018
Última transação
29/10/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
PLAN-LES-OUATES, GENEVA, CH
Examinador
LEE, JEANIE H
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
SWEDISH ORPHAN BIOVITRUM AG
EMACO SA
NovImmune SA
Representantes
Brendan J. Hughes COOLEY LLP
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biochemicalspolypeptidessuperantigensbiomarkers and antibodies for medical and scientific research; cellscell extracts and components of cells for medical and scientific research; diagnostic agents for medical and scientific research; diagnostic biomarker reagent for biomarker reagents for medical and scientific research; diagnostic test kits consisting primarily of biomarkers for medical and scientific research; biochemical test kits consisting of assays and reagents for medical and scientific research purposes
Classe 5
Pharmaceutical and biological preparations to treat immunologicalinflammatoryoncologicalviralinfectiousneurologicalmusculoskeletalrespiratorydermatological diseasesdisorders and conditions; pharmaceutical and biological preparations based on polypeptidessuperantigensbiomarkers and antibodies to treat immunologicalinflammatoryoncologicalviralinfectiousneurologicalmusculoskeletalrespiratorydermatological diseasesdisorders and conditions; Pharmaceutical and biological preparations and immunotherapies being medical preparations for stimulating the immune responseall for use in the diagnosispreventionmanagement and treatment of immunologicalinflammatoryoncologicalviralinfectiousneurologicalmusculoskeletalrespiratorydermatological diseasesdisorders and conditions; therapeutic and diagnostic agentspreparations and substances for medical purpose for use in therapies for immunologicalinflammatoryoncologicalviralinfectiousneurologicalmusculoskeletalrespiratorydermatological diseasesdisorders and conditions; biochemical substancepolypeptidesantibodiesbiomarkers and superantigens for use in diagnoses and therapies for immunologicalinflammatoryoncologicalviralinfectiousneurologicalmusculoskeletalrespiratorydermatological diseasesdisorders and conditions; engineered cell therapiesnamely engineered T cellsimmune cellsantibodies for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic test kits consisting primarily of biomarkers for medical purposes; biochemical test kits comprised of assays and reagents for medicaldiagnostic and therapeutic purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
18/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/10/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/10/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
18/10/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
18/10/2023
E815
TEAS SECTION 8 & 15 RECEIVED
30/08/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/07/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
20/04/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/04/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
20/04/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
20/04/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/04/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/04/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
20/04/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
25/01/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
17/07/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
03/07/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/04/2018
PUBO
PUBLISHED FOR OPPOSITION
17/04/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/03/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/03/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/03/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/03/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/03/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/11/2017
GNRT
NON-FINAL ACTION E-MAILED
02/11/2017
CNRT
NON-FINAL ACTION WRITTEN
02/11/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/10/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/10/2017
ALIE
ASSIGNED TO LIE
10/10/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/09/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/03/2017
GNRT
NON-FINAL ACTION E-MAILED
27/03/2017
CNRT
NON-FINAL ACTION WRITTEN
27/03/2017
DOCK
ASSIGNED TO EXAMINER
27/03/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/01/2017
NWAP
NEW APPLICATION ENTERED
02/01/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GAMIFANT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.